Cite
MLA Citation
Tony Mok et al.. “Tumor marker analyses from the phase III, placebo-controlled, FASTACT-2 study of intercalated erlotinib with gemcitabine/platinum in the first-line treatment of advanced non-small-cell lung cancer.” Lung cancer, vol. 98, 2016, pp. 1–8. http://access.bl.uk/ark:/81055/vdc_100034056922.0x000055